(NASDAQ: IOBT) Io Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 81.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.63%.
Io Biotech's revenue in 2025 is $0.On average, 4 Wall Street analysts forecast IOBT's revenue for 2026 to be $1,225,516,762, with the lowest IOBT revenue forecast at $309,640,296, and the highest IOBT revenue forecast at $2,227,301,941. On average, 4 Wall Street analysts forecast IOBT's revenue for 2027 to be $4,811,085,507, with the lowest IOBT revenue forecast at $1,600,906,210, and the highest IOBT revenue forecast at $6,868,019,404.
In 2028, IOBT is forecast to generate $10,443,837,773 in revenue, with the lowest revenue forecast at $3,326,986,157 and the highest revenue forecast at $15,561,071,887.